Medication info

Omnipar Plus One Injection

Prescription medicationInjections
Ingredient · strength
L-Alanine›1.052g / 100mLL-Arginine›0.584g / 100mLGlycine›0.523g / 100mLL-Histidine›0.244g / 100mLL-Isoleucine›0.305g / 100mLL-Leucine›0.371g / 100mLL-Lysine Hydrochloride›0.368g / 100mLL-Methionine›0.203g / 100mLL-Phenylalanine›0.284g / 100mLL-Proline›0.345g / 100mLL-Serine›0.254g / 100mLTaurine›0.051g / 100mLL-Threonine›0.213g / 100mLL-Tryptophan›0.091g / 100mLL-Tyrosine›0.02g / 100mLL-Valine›0.295g / 100mLCalcium Chloride Hydrate›0.038g / 100mLSodium Glycerophosphate Pentahydrate›0.301g / 100mLMagnesium Sulfate Heptahydrate›0.125g / 100mLPotassium Chloride›0.228g / 100mLSodium Acetate Hydrate›0.285g / 100mLZinc Sulfate Heptahydrate›0.0012g / 100mLGlucose Monohydrate›13.95g / 100mLSoybean Oil›0.76g / 100mLTriglycerides Medium-Chain›0.76g / 100mLPurified Olive Oil›1.045g / 100mLPurified Fish Oil (High Dose Omega-3 Fatty Acids)›1.235g / 100mL
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
It consists of a transparent colorless plastic inner bag divided into three compartments and an outer package, with an oxygen absorber placed between the compartments. Each compartment contains a transparent colorless to light yellow amino acid solution.
Packaging
986 mL / bag [A solution 500 mL, B solution 298 mL, C solution 188 mL], 1477 mL / bag [A solution 750 mL, B solution 446 mL, C solution 281 mL], 1970 mL / bag [A solution 1000 mL, B solution 595 mL, C solution 375 mL]
Approval status
Active

MFDS item code 202302670 · Approved 2023.09.07 · Insurance code 640007921,640007922,640007923

Summary

Main use
Correction of deficiencies in nutrients (amino acids, calories, fatty acids, etc.), fluids, and electrolytes
Who uses it
Adults · Children
Adult dosage
The dose and infusion rate are determined according to the patient's ability to eliminate fat and metabolize nitrogen and glucose, and nutritional requirements; the dose and bag size are determined according to the patient's condition and body weight. Trace elements, vitamins, electrolytes, etc. may be added according to the patient's condition. - Patients with normal nutritional status or mild metabolic stress: 0.10-0.15 g/kg/day as nitrogen (0.6-0.9 g/kg as amino acids) - Patients with moderate to severe metabolic stress, regardless of nutritional imbalance: 0.15-0.25 g/kg/day as nitrogen (0.9-1.6 g/kg as amino acids) In very special cases (e.g., burns or marked anabolic states), the amount of nitrogen may be higher. Dose A daily dose of 12-30 mL/kg of this medicine corresponds to 0.10-0.25 g/kg of nitrogen and total calories of 13-33 kcal/kg (non-protein calories 11-27 kcal/kg). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 2.0 mL/kg per hour (equivalent to glucose 0.25 g/kg, amino acids 0.10 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose varies according to the patient's clinical condition and may change from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides nitrogen 0.30 g/kg (1.8 g/kg as amino acids), glucose 4.4 g/kg, fat 1.33 g/kg, and total calories 38 kcal/kg (equivalent to 31 kcal/kg as non-protein calories). Method of administration Administer by intravenous infusion through a central vein.
Children's dosage
Use in children is not recommended.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Correction of deficiencies in nutrients (amino acids, calories, fatty acids, etc.), fluids, and electrolytes

View approved original text

This medication is used to supply necessary hydration, electrolytes, amino acids, calories, essential fatty acids, and omega-3 fatty acids via intravenous administration to patients who are unable to receive nutrition orally or through the gastrointestinal tract. This helps improve the nutritional status and maintain bodily functions.

Dosage and Administration

Adult dosage

The dose and infusion rate are determined according to the patient's ability to eliminate fat and metabolize nitrogen and glucose, and nutritional requirements; the dose and bag size are determined according to the patient's condition and body weight. Trace elements, vitamins, electrolytes, etc. may be added according to the patient's condition. - Patients with normal nutritional status or mild metabolic stress: 0.10-0.15 g/kg/day as nitrogen (0.6-0.9 g/kg as amino acids) - Patients with moderate to severe metabolic stress, regardless of nutritional imbalance: 0.15-0.25 g/kg/day as nitrogen (0.9-1.6 g/kg as amino acids) In very special cases (e.g., burns or marked anabolic states), the amount of nitrogen may be higher. Dose A daily dose of 12-30 mL/kg of this medicine corresponds to 0.10-0.25 g/kg of nitrogen and total calories of 13-33 kcal/kg (non-protein calories 11-27 kcal/kg). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 2.0 mL/kg per hour (equivalent to glucose 0.25 g/kg, amino acids 0.10 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose varies according to the patient's clinical condition and may change from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides nitrogen 0.30 g/kg (1.8 g/kg as amino acids), glucose 4.4 g/kg, fat 1.33 g/kg, and total calories 38 kcal/kg (equivalent to 31 kcal/kg as non-protein calories). Method of administration Administer by intravenous infusion through a central vein.

Children's dosage

Use in children is not recommended.

Precautions

This medication must be used strictly according to a physician's instructions. If allergic reactions such as fever, chills, rash, or difficulty breathing occur during administration, the infusion must be discontinued immediately. This medication may produce precipitation when mixed with certain drugs, therefore should not be administered simultaneously with drugs such as Ceftriaxone, and the injection equipment must be thoroughly cleaned if used for other drugs. Caution is required for premature or low-birth-weight infants, as they may have lower lipid removal capabilities and experience adverse reactions. This medication should not be given to individuals with allergies to fish, eggs, soybeans, peanuts, or patients with severe liver disease, renal failure, or blood coagulation disorders. Patients with conditions that may affect fat metabolism such as renal failure, diabetes, or liver dysfunction should be administered this medication with caution, and their blood sugar, electrolytes, and liver function should be monitored periodically during treatment. When administering this medication, strict aseptic techniques must be observed to prevent infection, and serum triglyceride levels should be checked regularly to prevent fat overload syndrome due to excessive administration. Excessive administration of amino acids or glucose can cause side effects such as nausea, vomiting, and hyperglycemia; therefore, the recommended dosage and infusion rate must be adhered to. The safety of this medication during pregnancy or lactation has not been established, and it should only be used when the therapeutic benefits outweigh the risks. Blood tests should be performed 5 to 6 hours after administration as fatty components can affect test results. In case of excessive administration, reduce or discontinue the infusion rate and seek appropriate emergency care if necessary. This medication should be stored at a temperature between 1°C and 25°C, kept in a sealed container to prevent air or moisture exposure. After mixing, it should be used promptly, and any remaining solution should be discarded.

Side effects

  • Paralytic ileus
  • intestinal obstruction
  • air embolism
  • abdominal-fluid accumulation
  • pleural effusion
  • atelectasis
  • pulmonary congestion
  • fever
  • hypertension
  • increased alanine aminotransferase
Show 30 more
  • increased amylase
  • increased aspartate aminotransferase
  • headache
  • hypophosphatemia
  • dysuria
  • vaginal bleeding
  • pruritus
  • fatty overload syndrome
  • hyperlipidemia
  • fever
  • fat infiltration
  • jaundice
  • hepatomegaly
  • splenomegaly
  • anemia
  • leukopenia
  • thrombocytopenia
  • coagulopathy
  • hemolysis
  • reticulocytosis
  • abnormal liver function test results
  • coma
  • nausea
  • vomiting
  • chills
  • sweating
  • elevated body temperature
  • increased nitrogen levels
  • hyperglycemia
  • allergic reaction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent the entry of air and moisture. It is important to maintain a storage temperature between 1°C and 25°C.

Appearance and packaging

Appearance

It consists of a transparent colorless plastic inner bag divided into three compartments and an outer package, with an oxygen absorber placed between the compartments. Each compartment contains a transparent colorless to light yellow amino acid solution.

Package unit

986 mL / bag [A solution 500 mL, B solution 298 mL, C solution 188 mL], 1477 mL / bag [A solution 750 mL, B solution 446 mL, C solution 281 mL], 1970 mL / bag [A solution 1000 mL, B solution 595 mL, C solution 375 mL]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.